The Beverly Hills team at RR Aesthetics patiently await the approval of Daxibotulinumtoxin A for Injection for the treatment of moderate to severe glabellar lines. Approval is set for late 2022 or early 2023. Stay tuned for more details as they become available.
What is Daxi?
Daxi is somewhat similar to other toxins on the market. It is injected into the glabellar area to stop muscle movement and smooth out those worry lines between your brows. We have all heard of the top 4; Botox, Dysport, Jeaveau, and Xeomin. Daxi will make the 5th toxin on the market but with a marked difference. This innovative formulation is projected to have a longer duration than any toxin on the market. At ASDS 2019/2020 and ADD 2020, 6 months median duration of effect was presented for Daxibotulinumtoxin A.
Serving Beverly Hills and the Los Angeles area, the team at RR Aesthetics will update you as soon as Daxi is approved by the FDA.